-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/pelvic-pain_research-protocol.pdf
February 16, 2011 - scientific evidence (level A) for using combined oral
contraceptives and nonsteroidal anti-inflammatory drugs … Medical therapies
• Analgesics
o Non-narcotic agents including nonsteroidal anti-inflammatory drugs … Broad searches for grey literature
and regulatory information on such commonly used drugs would likely … We consulted the TEP to determine which studies of drugs or devices would be likely to
provide relevant … Our research
team also thought it important to search for other drugs (e.g., aromatase inhibitors) that
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/methods_guide_atkins.pdf
January 01, 2011 - For example, the individual trials of statin drugs to treat high
cholesterol each selected specific … and discrete populations, used different drugs, different
dosages, and different cointerventions. … differing risks,
nationalities, and underlying conditions provides evidence that the benefits of statin drugs … Drugs
2007;67(14):1969-1979.
20. Walker, CF, Kordas K, Stoltzfus, RJ, et al. … Drug class review of Alzheimer’s drugs.
Final report. 2006.
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/back-pain-treatment_consumer.pdf
November 01, 2016 - Pain
Type of Medicine About the medicine: Researchers found:
NSAIDs (nonsteroidal anti-
inflammatory drugs … Type of Medicine About the medicine: Researchers found:
NSAIDs (nonsteroidal anti-
inflammatory drugs … Possible Side Effects
NSAIDs (nonsteroidal anti-inflammatory drugs) – Celecoxib (Celebrex®), diclofenac
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/stent-clopidogrel-practice_research.pdf
March 01, 2009 - the Agency for Healthcare Research and Quality, Proctor and Gamble, Pfizer, Medtronic, Alexion
Pharmaceuticals … , Medicure, Medtronic Vascular, Bristol-Myers Squibb, and Novartis Pharmaceuticals. … Institute, the Agency for Healthcare Research and Quality, Proctor & Gamble, Pfizer,
Medtronic, Alexion Pharmaceuticals
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/diabetes-horizon-scan-high-impact-1412.pdf
January 01, 2015 - health care sector, horizon
scanning pertains to identification of new (and new uses of existing) pharmaceuticals … Information is compiled for expert comment on topics at a granular
level (i.e., similar drugs in the … Results
The table below lists the four topics for which (1) preliminary phase III data for drugs, at … San Diego (CA): Amylin
Pharmaceuticals, Inc.; 2012 Jan 27 [accessed
2014 Apr 10]. [5 p]. … Get drugs straight to the eye.
[internet].
-
effectivehealthcare-admin.ahrq.gov/products/rheumatoid-arthritis-2007/research
December 01, 2019 - Skip to main content
An official website of the Department of Health & Human Services
Careers
Contact Us
Español
FAQs
Effective Health Care Program
Powered by the Evidence-based Practice Centers
…
-
effectivehealthcare-admin.ahrq.gov/health-topics/eye-diseases
April 18, 2013 - Research Protocol Archived March 9, 2010
The Effectiveness of Disease-Modifying Antirheumatic Drugs
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/diabetes-glucose-control_research.pdf
July 01, 2010 - Exenatide, manufactured as Byetta by Amylin Pharmaceuticals, Inc. … Additionally, a separate, linkable
file is available which includes pharmacy claims for prescription drugs … In Table 3, we provide details about the other drugs for DM used by these patients. … Experts weigh in on promotion,
prescription of off-label drugs. JAMA
2007;297:683-684.
15.
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/diabetic-neuropathy-disposition-170707.pdf
March 24, 2017 - Given the
extensive detail on harms for these drugs, we
were unable to summarize in a row and have … rather than redoing the entire
meta-analysis, we chose to do focused meta-
analyses just on those drugs … discussion: “In addition,
larger, higher-quality studies have almost all
been conducted with new drugs … with
pharmaceutical company funding, and these
were the only drugs with moderate strength of
evidence … treatments improved quality
of life, studies were short-term with unclear risk of
bias, all oral drugs
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/diabetic-neuropathy-disposition-170707.pdf
March 24, 2017 - Given the
extensive detail on harms for these drugs, we
were unable to summarize in a row and have … rather than redoing the entire
meta-analysis, we chose to do focused meta-
analyses just on those drugs … discussion: “In addition,
larger, higher-quality studies have almost all
been conducted with new drugs … with
pharmaceutical company funding, and these
were the only drugs with moderate strength of
evidence … treatments improved quality
of life, studies were short-term with unclear risk of
bias, all oral drugs
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/osteoarthritis-pain-2006_appendixes.pdf
January 01, 2006 - Pharmacokinetics, Indications and
Dosing of Included Drugs
Drug and Trade
Name
(Trade names … provided only for
drugs under
patent.) … incapaciation
and definite hazard to patient's
health; adverse events defined
according to Compendium of
Pharmaceuticals … having a
therapeutic
effecton the
knee joint)
no yes Dolorgiet
Pharmaceuticals
(Germany … Pharmacokinetics, Indications and Dosing of Included Drugs
Appendix B.
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/multiple-sclerosis_research-protocol.pdf
December 17, 2013 - Thus, major questions
of interest are whether or not disease-modifying MS drugs alter the natural history … evidence for patient values, beliefs, and preferences regarding discontinuation of disease-
modifying drugs … KQ2: What are individual values, beliefs, and preferences regarding discontinuing
disease-modifying drugs … Since these drugs are intended for long-term use, possibly for decades, we are
looking for studies that … FDA-approved disease modifying drugs
were only available after 1993.
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/diabetes-horizon-scan-high-impact-1506.pdf
June 01, 2015 - health care sector, horizon
scanning pertains to identification of new (and new uses of existing) pharmaceuticals … Results
The table below lists the five topics for which (1) preliminary phase III data for drugs, at … San Diego (CA): Amylin
Pharmaceuticals, Inc.; 2012 Jan 27 [accessed
2014 Apr 10]. [5 p]. … Med Lett Drugs
Ther. 2013 Dec 9;55(1431):97-8. PMID:
24322663.
74. … Drugs. 2013 Feb;73(2):187-93. PMID:
23335133.
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/pneumonia-antibiotic-treatment_research-protocol.pdf
July 19, 2013 - significantly for patients
with HAP.3-6 Optimal treatment involves choosing the right drug or combination of drugs … For drugs with a narrow
therapeutic index, such as vancomycin and the aminoglycosides, the risk of toxicities … also reduce nephrotoxicity in patients who are receiving aggressive
dosing, concurrent nephrotoxic drugs … discussion, a new KQ was
added to examine the effect of using prolonged or continuous infusions of drugs … creatinine
clearance, time above MIC, and ratio of AUC to MIC (see Table 1 below for drug classes
and drugs
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/chronic-pain-opioid-treatment_disposition-comments.pdf
September 29, 2014 - decade ago the FDA established a 12-week duration of
observation as a requirement for approval of drugs … behavior in persons with a legitimate (if not always appropriate) need to
use the opioid class of drugs … opioid drug abuse
and misuse, while simultaneously enabling appropriate access to pain-relieving
drugs … Without considering how opioids should be used in
the context of other drugs, devices or techniques, … in its class. ii
Methadone’s unique properties distinguish it from other opioid drugs.
-
effectivehealthcare-admin.ahrq.gov/products/mhs4-computerized-cds/rapid-research
February 01, 2024 - Skip to main content
An official website of the Department of Health & Human Services
Careers
Contact Us
Español
FAQs
Effective Health Care Program
Powered by the Evidence-based Practice Centers
…
-
effectivehealthcare-admin.ahrq.gov/health-topics/drug-safety
Skip to main content
An official website of the Department of Health & Human Services
Careers
Contact Us
Español
FAQs
Effective Health Care Program
Powered by the Evidence-based Practice Centers
…
-
effectivehealthcare-admin.ahrq.gov/health-topics/immune-system-and-disorders?page=2
May 02, 2011 - Research Protocol Archived March 9, 2010
The Effectiveness of Disease-Modifying Antirheumatic Drugs
-
effectivehealthcare-admin.ahrq.gov/products/mhs4-computerized-cds/protocol
September 01, 2023 - Skip to main content
An official website of the Department of Health & Human Services
Careers
Contact Us
Español
FAQs
Effective Health Care Program
Powered by the Evidence-based Practice Centers
…
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/s143.pdf
October 01, 2007 - Key Words: cohort studies, propensity scores, observational
research
(Med Care 2007;45: S143–S148)
Drugs … Statins inhibit endogenous cholesterol synthesis, and ther-
apy with these drugs improves lipoprotein … including
ambulatory care, approved specialists and outside referrals,
laboratory work, and prescription drugs